Transcript Introduction to IDA Foundation

Update by IDA Foundation
Leontien Ruttenberg MSc MBA
Introducing IDA Foundation
…a not-for-profit supplier of essential medicines and
medical supplies since 1972
Our mission:
“To improve access to and deliver high-quality medicines and
medical supplies at the lowest possible price
to low and middle income countries.”
IDA Foundation: global presence
•
•
•
•
Customers in 130+ countries
40+ agents worldwide & 10 locations with stock
Head office in Amsterdam (110 employees)
Procurement office in Mumbai (65 employees)
Customers and partners
NGO & PRIVATE
FOUNDATIONS
MULTILATERAL FUNDING
The Global Fund to Fight Aids,
Tuberculosis and Malaria
Clinton Health
Access Initiative
(CHAI)
Drug-purchasing facility (provides
funding grants) Hosted by WHO
Local
NGOs
The World Bank
President’s
Emergency
Plan for AIDS
Relief
(PEPFAR)
PRESIDENT’S
MALARIA
INITIATIVE (PMI)
World Health
Organisation
National
Ministries of
Health (MoH)
Central Medical
Stores
GLOBAL DRUG FACILITY (GDF)
The Global Health Network
MULTILATERAL PROGRAM & FUNDING
BILATERAL
IDA Foundation : key facts 2014
• Multi-channel approach
• Procurement Services, wholesale & tender proposals
•
•
•
•
Portfolio of > 3000 products
Stock keeping 750 products
Average stock value: € 12 million
Increased turnover over the years with customer ranging
from hospitals to large donors
• Emergency response
• 4 Global PA contracts (GDF (2), CHAI, PPM)
• 2 National PA contracts(Togo, Nigeria)
• 30 Audits
IDA Quality
Guaranteed quality for pharmaceuticals and medical supplies*
(*process may vary depending on risk class)
More than quality control ‘on paper’  verification audits, samples
Leading in quality innovation: role in MQAS, WHO working groups
Own product: registrations in destination country
Dedicated pharmacists in our QA / QC teams in NL, Mumbai, China
Update on achievements 2014
Product range:
• RMNCH: reviewed portfolio to include UN 13
commodities
• NCD: reviewed portfolio, added 26 anti-cancer drugs to
be completed in Q1, 2015
• HIV/AIDS ; increased focus – re-establish value added
Quality
• Bioequivalence studies
Supply Chain Management
• Custom – made kitting projects / more complex supply
chain solutions
Update on challenges 2014
Product range:
• Stock keeping, shelf-life requirements, lead time
• Local manufacturing – price differences w/ Asian
generics
• Registration
Lack of standardization in medical devices
• No standard list
• No standard quality guidelines
Quality
• Bioequivalence studies
• Harmonization QA guidelines
• Focus on local manufacturers may jeopardize uniformity
(eg Universal)
• Complying to different standards costs time/donor money
Any Questions / Feedback?
Contact: [email protected]
www.idafoundation.org
Join us on:
IDA.Foundation.Amsterdam
IDA_Foundation
Summary
• IDA continues to passionately serve
unmet needs
• Not for profit, independant &
transparant
• Looking forward to increased
harmonization
• Partnership approach